With First ANDA Approval, PL Development Adds Ibuprofen Manufacturing As Growth Driver
This article was originally published in The Tan Sheet
FDA approves private label firm PL Developments’ ANDA to make store brand ibuprofen in its manufacturing facility, giving the firm more control over its supply chain and possible market share gains against national brands and other generics providers, says President Evan Singer.
You may also be interested in...
At least one FTC commissioner seems convinced that the agency’s Enforcement Guides are ripe for an update to address unscrupulous influencer marketing practices. Democrat Rohit Chopra proposes their codification into formal rules that would make violators liable for civil penalties and damages.